Gr. Sarantis (SSA1) Stock Overview
Produces and trades in cosmetics, household products, and pharmaceutical items in Greece, Portugal, Poland, Romania, Bulgaria, Serbia, Bosnia and Herzegovina, North Macedonia, Slovenia, Croatia, Czech-Slovakia, Hungary, and Ukraine. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
SSA1 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Gr. Sarantis S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.44 |
| 52 Week High | €15.40 |
| 52 Week Low | €11.98 |
| Beta | 0.54 |
| 1 Month Change | -13.61% |
| 3 Month Change | -15.83% |
| 1 Year Change | -8.12% |
| 3 Year Change | 61.14% |
| 5 Year Change | 42.82% |
| Change since IPO | 864.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| SSA1 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -8.5% | -0.3% | -2.2% |
| 1Y | -8.1% | -4.4% | 3.4% |
Return vs Industry: SSA1 underperformed the German Personal Products industry which returned -6.4% over the past year.
Return vs Market: SSA1 underperformed the German Market which returned 4% over the past year.
Price Volatility
| SSA1 volatility | |
|---|---|
| SSA1 Average Weekly Movement | 3.3% |
| Personal Products Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: SSA1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: SSA1's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1930 | 2,619 | Giannis Bouras | sarantisgroup.com |
Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and pharmaceutical items in Greece, Portugal, Poland, Romania, Bulgaria, Serbia, Bosnia and Herzegovina, North Macedonia, Slovenia, Croatia, Czech-Slovakia, Hungary, and Ukraine. It operates through Beauty/Skin/Sun Care, Personal Care, Home Care Solutions, Private Label, and Strategic Partnerships segments. The company offers personal and health care products, including food supplements, health and self-care, baby care, body wash, deodorants, fragrances, grooming, hair care and styling, hand wash, oral care, personal hygiene, and skin and sun care.
Gr. Sarantis S.A. Fundamentals Summary
| SSA1 fundamental statistics | |
|---|---|
| Market cap | €770.38m |
| Earnings (TTM) | €50.77m |
| Revenue (TTM) | €603.59m |
Is SSA1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SSA1 income statement (TTM) | |
|---|---|
| Revenue | €603.59m |
| Cost of Revenue | €379.35m |
| Gross Profit | €224.24m |
| Other Expenses | €173.47m |
| Earnings | €50.77m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 37.15% |
| Net Profit Margin | 8.41% |
| Debt/Equity Ratio | 16.2% |
How did SSA1 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/14 11:30 |
| End of Day Share Price | 2026/09/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Gr. Sarantis S.A. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Manos Chatzidakis | Beta Securities S.A. |
| Dimitris Giannoulis | Deutsche Bank |
| Natalia Svyrou Svyriadi | Eurobank Equities Investment Firm S.A. |